Alethia Young - Apr 1, 2022 Form 4 Insider Report for Graphite Bio, Inc. (GRPH)

Role
Chief Financial Officer
Signature
/s/ Zed Zduniak, attorney-in-fact
Stock symbol
GRPH
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 06:01 PM
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRPH Stock Option (right to buy) Award $0 +350K $0.00 350K Apr 1, 2022 Common Stock 350K $5.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to such option will vest and become exercisable on April 1, 2023 and 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.